Zobrazeno 1 - 10
of 248
pro vyhledávání: '"B. Demuynck"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Salvador Fernández-Arroyo, S. Decaudaveine, C. Benoist-Lasselin, M. Cornille, Nabil Kaci, Laurence Legeai-Mallet, J. Flipo, Florent Barbault, Antonio Segura-Carretero, V. Estibals, Léa Loisay, M. De La Luz Cadiz-Gurrea, B. Demuynck, M. Mondoloni, Emilie Dambroise, Laurent Martin, Laurent Schibler
A gain-of-function mutation in the fibroblast growth factor receptor 3 gene (FGFR3) results in achondroplasia (ACH), the most frequent form of dwarfism. The constitutive activation of FGFR3 impaired bone formation and elongation and many signaling tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13034b2056f920089cc9d074c3bbf152
https://doi.org/10.1101/2021.02.18.431801
https://doi.org/10.1101/2021.02.18.431801
Autor:
Ghosh, Rana1,2, Das, Ankan1,3, Gorai, Prasanta4,5 prasanta.astro@gmail.com, Mondal, Suman Kumar6, Furuya, Kenji7,8, Tanaka, Kei E. I.9, Takashi Shimonishi10, Fontani, Francesco11
Publikováno v:
Frontiers in Astronomy & Space Sciences. 2024, p01-25. 25p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C. Louvet, M Kulik, B. Demuynck, C. Varette, K. Beerblock, A. de Gramont, F Destroys du Roure
Publikováno v:
La Revue de Médecine Interne. 15:48-51
Resume Une patiente de 58 ans a ete hospitalisee pour accident vasculaire cerebral associe a une coagulopathie de consommation. Le bilan etiologique de cette coagulopathie permit de mettre en evidence un adenocarcinome ovarien a cellules claires de s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e45fd9ad9abdc59949c0e8d9873933ad
https://doi.org/10.1016/s0248-8663(05)82130-7
https://doi.org/10.1016/s0248-8663(05)82130-7
Autor:
E Raymond, B. Demuynck
Publikováno v:
La Revue de Médecine Interne. 15:233-237
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e4977606430f2d3cadc868ce876b45f
https://doi.org/10.1016/s0248-8663(94)80025-1
https://doi.org/10.1016/s0248-8663(94)80025-1
Autor:
Sainsily-Cesarus, Adele1,2 (AUTHOR), Schmitt, Elise1,3 (AUTHOR) elise.schmitt@chru-strasbourg.fr, Landre, Lionel2 (AUTHOR), Botzung, Anne1 (AUTHOR), Rauch, Lucie1 (AUTHOR), Demuynck, Catherine1 (AUTHOR), Philippi, Nathalie1,2 (AUTHOR), de Sousa, Paulo Loureiro2 (AUTHOR), Mutter, Catherine4 (AUTHOR), Cretin, Benjamin1,2 (AUTHOR), Martin-Hunyadi, Catherine1,2 (AUTHOR), Blanc, Frederic1,2 (AUTHOR)
Publikováno v:
Alzheimer's Research & Therapy. 7/30/2024, Vol. 16 Issue 1, p1-10. 10p.
Autor:
A. Pigne, Aimery de Gramont, Dominique Soubrane, Marcel Krulik, Loïc Marpeau, Thierry Guillot, C. Varette, Christophe Louvet, K. Beerblock, B. Demuynck
Publikováno v:
European Journal of Cancer. 29:1835-1838
60 patients with metastatic breast cancer were entered in a phase II study using folinic acid, 5-fluorouracil bolus and infusion and mitoxantrone with or without cyclophosphamide. 47 had measurable visceral metastases and 13 had exclusively bone meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::491b201f4f087869b3352ba7e16c1e74
https://doi.org/10.1016/0959-8049(93)90532-k
https://doi.org/10.1016/0959-8049(93)90532-k
Autor:
Jean-Didier Grangé, C. Louvet, C. Varette, B. Demuynck, Marcel Krulik, K. Beerblock, A. de Gramont, D. Soubrane, E Navarro-Carola
Publikováno v:
La Revue de Médecine Interne. 14:821-824
We studied the levamisole toxic effects in adjuvant therapy for colorectal cancer. The therapy toxic effects on 127 patients were statistically more important in the levamisole-treated group compared to patients treated with folinic acid and 5-fluoro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef3108564f9878bbca8651323629106d
https://doi.org/10.1016/s0248-8663(05)81139-7
https://doi.org/10.1016/s0248-8663(05)81139-7
Autor:
B. Lagadec, Jean Cady, Marcel Krulik, S. Delfau, B. Demuynck, D. Gallot, M. Malafosse, Alain Sezeur, C. Varette, Loïc Marpeau, A. Pigne, Christophe Louvet, Barrat J, Jean-Yves Couturier, Aimery de Gramont
Publikováno v:
European Journal of Cancer. 28:53-58
40 patients with advanced ovarian cancer were treated with immediate debulking followed by sequential cisplatin and doxorubicin every 4 weeks, followed by second-look laparotomy (SLL). Six courses were given when residual disease (RD) was under 2 cm.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6a73e2f9ba892ad192825766fbd5fa4
https://doi.org/10.1016/0959-8049(92)90384-e
https://doi.org/10.1016/0959-8049(92)90384-e